Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
Benvenisty
A I
AI
Columbia University College of Physicians and Surgeons, New York, NY 10032.
Tannenbaum
G A
GA
Cohen
D J
DJ
Appel
G
G
Hardy
M A
MA
D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D004351:Drug Resistance; D006084:Graft Rejection / Q000276:immunology*; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008775:Methylprednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D011241:Prednisone; D008775:Methylprednisolone